Skip to content

Dr. Jan De Vlieger

Active Private limited companyfounded 2019active for 7 yearsStationsstraat 48, 9250 WaasmunsterKBO/BCE: BE 0725.813.188

Lifetime

7 annual accounts with figures on one time axis
peak of €552,971 in 2026
€552,971▲ 11.3%
peak of €423,319 in 2026
€423,319▲ 23.4%
peak of €1.1m in 2026
€1.1m▲ 65.2%
€17,069▼ 35.9%
Board2 names since 2019
2 directors and 1 other
Documentsfilings and deeds
05-10-202626 days before the deadline
2026micro format
Equity from €649,402 to €1.1mDebts from €26,649 to €17,069Cash from €21,543 to €394,020

Key points

from the 2026 annual accounts

Equity

€1.1m ▲ 65.2%
€649,0002025€1.1m2026

Equity rose in 2026 from €649,402 to €1.1m.

Turnover

≈ €830,000 estimated

The micro format states no turnover.

Liquidity

63.84 was 25.36 in 2025

Short-term debts fell from €26,649 to €17,069.

Filings

7 annual accounts 1 late
deadline2020202220242026

The 2024 accounts came 5 days late. The other six were filed on time.

Position in the sector

98.4%

Higher solvency than 95% of companies in human health. Sector median 70.2% · 547 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,785 companies had the same profile as Dr. Jan De Vlieger has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,785 companies, not a prediction for Dr. Jan De Vlieger. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 20 sharesdeed of 02-05-2019
Board & ownership

Recent changes

changes role from manager to director Director discharge: · General meeting of 17-04-2023 · Gazette deed
Incorporation Founding capital of €20,000, 20 shares · Founded by · appointed as manager · published on 02-05-2019 · Gazette deed
First establishment Stationsstraat 48, Waasmunster
All 19 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Jan De Vlieger Waasmunster €1.1m €552,971 98.4% -
Dr. Jerrold SPAPEN, Cardiologie Aalst €1.0m €557,444 38.5% -
Dr. Christophe Balliauw Hasselt €1.0m €554,138 44.3% -
Dr. Jeroen Vandenbrande Hasselt €1.0m €509,400 33.0% -
Dr. Jurgen Bielen Hasselt €1.1m €598,731 88.9% -
Dr. Benjamin Peters Schilde €1.2m €522,224 87.7% -
Dokter Nele Myngheer, Endocrino-diabetologie Kortrijk €1.2m €502,349 5.2% -

These companies have the same main activity as Dr. Jan De Vlieger: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €1.2m, founded between 2018 and 2020.

Official details

Source: KBO
Status
Active since 29-04-2019Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.288.844.9599250 Waasmunster, since 29-04-2019
Financial year end
31 March
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 31-03-2026

€1.1m▲ 61.2%
Filing
Filed on 05-10-2026, 26 days before the end of the filing period
Financials

Insights on Dr. Jan De Vlieger

Dr. Jan De Vlieger files the micro format. That format states no turnover. The gross margin rose from €41,114 in 2020 to €552,971 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Jan De Vlieger

What is the company number of Dr. Jan De Vlieger?
The company number of Dr. Jan De Vlieger is 0725.813.188. The VAT number is the same number with BE in front: BE 0725.813.188.
Where is Dr. Jan De Vlieger based?
The registered office is at Stationsstraat 48, 9250 Waasmunster.Company details
What does Dr. Jan De Vlieger do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Jan De Vlieger?
Dr. Jan De Vlieger is a private limited company (BV).
When was Dr. Jan De Vlieger founded?
Dr. Jan De Vlieger was founded on 29-04-2019.
Is Dr. Jan De Vlieger still active?
Yes, Dr. Jan De Vlieger is an active enterprise in the KBO register.
What is the turnover of Dr. Jan De Vlieger?
The turnover in financial year 2026 is ≈ €830,000. This figure is estimated from the gross margin of €552,971 and 31 comparable companies (NACE 86220). It probably lies between €740,000 and €1.2m.Financials
Is Dr. Jan De Vlieger profitable?
In financial year 2026, Dr. Jan De Vlieger made a profit of €423,319.
Where can I find the annual accounts of Dr. Jan De Vlieger?
Dr. Jan De Vlieger filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of Dr. Jan De Vlieger due?
Dr. Jan De Vlieger must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.